Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
Authors:
- Norio KatohNKNorio Katoh
- Itaru SodaISItaru Soda
- Hiroyasu TamamuraHTHiroyasu Tamamura
- Shotaro TakahashiSTShotaro Takahashi
- Yusuke UchinamiYUYusuke Uchinami
- Hiromichi IshiyamaHIHiromichi Ishiyama
- Kiyotaka OtaKOKiyotaka Ota
- Tetsuya InoueTITetsuya Inoue
- Rikiya OnimaruRORikiya Onimaru
- Keiko ShibuyaKSKeiko Shibuya
- Kazushige HayakawaKHKazushige Hayakawa
- Hiroki ShiratoHSHiroki Shirato
Open Access
- 5 January 2017
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 1-10
Abstract
To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52–90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0–127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) ≥ 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm.Keywords
Funding Information
- JSPS KAKENHI (JP15H04768)
- The Ministry of Education, Culture, Sports, Science and Technology MEXT, Japan
This publication has 44 references indexed in Scilit:
- Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapyRadiotherapy and Oncology, 2016
- Stereotactic body radiation therapy versus no treatment for early stage non–small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysisCancer, 2015
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsThe Lancet Oncology, 2015
- Early response and local control of stage I non‐small‐cell lung cancer after stereotactic radiotherapy: difference by histologyCancer Science, 2012
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapyRadiotherapy and Oncology, 2009
- Histopathologic Consideration of Fiducial Gold Markers Inserted for Real-Time Tumor-Tracking Radiotherapy Against Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Detection of lung tumor movement in real-time tumor-tracking radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000